Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$569K Buy
+4,425
New +$518K 0.17% 68
2025
Q4
Sell
-7,234
Closed -$607K 74
2025
Q3
$607K Buy
7,234
+1,597
+28% +$132K 0.22% 51
2025
Q2
$446K Buy
5,637
+2,072
+58% +$165K 0.17% 51
2025
Q1
$320K Buy
3,565
+128
+4% +$12K 0.15% 45
2024
Q4
$342K Buy
3,437
+697
+25% +$71.9K 0.16% 40
2024
Q3
$311K Sell
2,740
-91
-3% -$10.8K 0.15% 41
2024
Q2
$350K Buy
2,831
+78
+3% +$10K 0.16% 39
2024
Q1
$363K Buy
2,753
+477
+21% +$58.8K 0.17% 35
2023
Q4
$248K Buy
+2,276
New +$236K 0.13% 39

Other funds holding MRK

Saiph Capital's MRK Position: Q2 2026 in Review

Saiph Capital opened a new position in Merck (MRK) in Q2 2026: 4,425 shares worth $569K. The stake represents 0.17% of the portfolio and ranks #68 among its holdings. This is a return to the name: Saiph Capital previously reported a position in MRK as recently as Q3 2025.

Saiph Capital first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $607K in Q3 2025. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Saiph Capital held 4,425 shares of Merck worth $569K as of Q2 2026.
  • Merck was a new Saiph Capital position in Q2 2026.
  • Merck made up 0.17% of Saiph Capital's portfolio in Q2 2026, its #68 holding.
  • Saiph Capital first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Saiph Capital's Merck position peaked at $607K in Q3 2025.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Saiph Capital's 13F filing for Q2 2026, filed 29 Jul 2026.